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Regulatory T (Treg) cells suppress immune responses
to a broad range of non-microbial and microbial anti-
gens and indirectly limit immune inflammation-in-
flicted tissue damage by employing multiple mecha-
nisms of suppression. Here, we demonstrate that
selective Treg cell deficiency in amphiregulin leads
to severe acute lung damage and decreased blood
oxygen concentration during influenza virus infection
without any measureable alterations in Treg cell sup-
pressor function, antiviral immune responses, or viral
load. This tissue repair modality is mobilized in Treg
cells in response to inflammatory mediator IL-18 or
alarmin IL-33, butnotbyTCRsignaling that is required
for suppressor function. These results suggest that,
during infectious lung injury, Treg cells have a major
direct and non-redundant role in tissue repair and
maintenance—distinct from their role in suppression
of immune responses and inflammation—and that
these two essential Treg cell functions are invoked
by separable cues.
INTRODUCTION
Regulatory T (Treg) cells expressing X-chromosome-encoded
transcription factor Foxp3 represent a specialized lineage of
T lymphocytes whose key function is suppression of T cell re-
sponses to self, the commensal microbiota, and dietary and
environmental antigens (Josefowicz et al., 2012; Sakaguchi
et al., 2008). Congenital deficiency in Treg cells in mice and hu-
mans—or their acute elimination—results in fatal autoimmunity,
associated with splenomegaly and lymphadenopathy and
destructive inflammatory damage to numerous non-lymphoid
organs, including the lung, stomach, small and large intestine,
pancreas and other endocrine glands, liver, and skin (Fontenot
et al., 2003; Khattri et al., 2003). In addition to the maintenance
of immunological tolerance to ‘‘self’’ and non-‘‘self’’ antigens
that the organism is chronically exposed to, Treg cells have
been implicated in limiting immune responses to acute and
chronic microbial infections and also limiting corresponding tis-1078 Cell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc.sue damage (see for review Josefowicz et al., 2012 and Veiga-
Parga et al., 2013). Treg cells employ multiple mechanisms of
suppression (Josefowicz et al., 2012), and genetic ablation of
the T cell receptor (TCR) in differentiated Treg cells recently re-
vealed that TCR signaling is prerequisite for their suppressor
function (Levine et al., 2014).
Aside from limiting tissue damage through suppression of in-
flammatory responses following infection, Treg cells may pro-
mote tissue repair. One way in which Treg-cell-mediated tissue
repair is thought to occur is by suppressing pro-inflammatory
chemokine production, endothelial cell activation, and pro-
inflammatory responses of cells of the innate and adaptive im-
mune system (Burzyn et al., 2013a).
In addition to secondary lymphoid organs, Treg cells reside
within a number of non-lymphoid organs, where circulatory
Treg cells are rapidly recruited, and the resident Treg cells
expand upon tissue damage or injury (Burzyn et al., 2013a;
D’Alessio et al., 2009). Therefore, we reasoned that, in addition
to their aforementioned indirect role in response to tissue injury
and stress, Treg cells likely play a direct role in tissue repair
and function by elaborating mediators acting on parenchymal
cells. In support of this idea, analysis of published datasets
and unpublished data from our laboratory indicates that tissue-
resident populations of Treg cells exhibit features evoking
tissue-remodeling capability (data not shown) (Burzyn et al.,
2013b). Specifically, the epidermal growth factor receptor
(EGF-R) ligand amphiregulin is expressed in Treg cells isolated
from visceral adipose tissue (VAT), muscle, and the intestinal
lamina propria (LP) during inflammation (Burzyn et al., 2013b;
Cipolletta et al., 2012; Feuerer et al., 2009; Schiering et al.,
2014). Amphiregulin plays an important role in development
and maintenance of numerous organs, including mammary
glands and ovaries. It also promotes repair under inflammatory
conditions and organ injury by acting locally in its mem-
brane-bound form and upon its cleavage, primarily by TACE
(ADAM17) protease (Berasain and Avila, 2014).
As indirect evidence of a biological role for amphiregulin
production by Treg cells, acute ablation of Treg cells during
muscle injury has been shown to impede tissue repair and could
be ameliorated by administration of recombinant amphiregulin
protein (Burzyn et al., 2013b). However, amphiregulin production
by multiple cell types, including group 2 innate lymphoid cells
(ILC2), and basophils has been implicated in tissue repair
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Figure 1. In Vitro Amphiregulin Production by Treg andConventional
CD4+ T Cells
(A and B) Amphiregulin expression by Treg cells and conventional CD4+ T cells
with an effector/memory cell phenotype.
(A) Flow cytometric analysis for amphiregulin (Areg) and Foxp3 expression in
CD4+TCRb+ cells isolated from spleens, axillary and inguinal (pLN) and
mesenteric (MLN) lymph nodes, lungs, and LILP of C57BL/6 mice following
in vitro stimulation for 3 hr with PMA and ionomycin in the presence of brefeldin
A. Amphiregulin+ Treg (green) and conventional CD4+ T cells (orange) and
amphiregulin– Treg cells (blue). The frequencies of cells within each gate are
shown.
(B) Flow cytometric analysis of surface and intracellular Treg cell activation
markers. Histograms depict expression in amphiregulin–CD4+Foxp3+ (blue) or
CD4+Foxp3+amphiregulin+ (green) populations as gated in (A). Data represent
one of three independent experiments, each with nR 3 mice.
See also Figure S1.(Meulenbroeks et al., 2015; Monticelli et al., 2011). Furthermore,
it is not clear to what extent therapeutic dosing of recombinant
amphiregulin corresponds to its physiological systemic and
local concentrations (Berasain and Avila, 2014). Therefore, it is
possible that systemic delivery of amphiregulin can overridecompromised tissue repair resulting from Treg cell depletion.
Moreover, several recent studies suggested that amphiregulin
produced by mast cells and basophils has a non-redundant
immunosuppressive function and that amphiregulin may act in
an autocrine manner on Treg cells to facilitate their suppressor
capacity (Meulenbroeks et al., 2015; Zaiss et al., 2013, 2015).
Thus, it remains unknown whether its production by Treg cells
has a distinct non-redundant role in, or is dispensable for, tissue
repair or whether amphiregulin expression by Treg cells has
immunosuppressive function along with other mediators.
We sought to unequivocally address these questions and test
the hypothesis that amphiregulin production by Treg cells de-
fines their distinct tissue repair modality. The absence of Treg-
cell-derived amphiregulin conferred a marked increase in acute
lung damage upon influenza virus infection, whereas viral load
and T cell responses were unaffected. Our results suggest that
Treg cells can adopt distinct—albeit non-mutually exclusive—
effector states depending on the type of activating stimuli they
receive. Through coordinate utilization of these effector mecha-
nisms, tissue-resident Treg cells are capable of acting as univer-
sal sentinels of mucosal barriers—rapidly responding to tissue
damage and immune-mediated inflammation to promote toler-
ance, tissue repair, and restore function.
RESULTS
Treg- and T-Cell-Specific Ablation of Amphiregulin
Knowing that both Treg cells and conventional T cells have been
reported to produce amphiregulin during an immune response
(Burzyn et al., 2013b; Jamieson et al., 2013; Qi et al., 2012; Zaiss
et al., 2006), we assessed its production by purified T cell popu-
lations following in vitro stimulation. T cells isolated from the
spleen and axillary and inguinal (pLN) and mesenteric (MLN)
lymph nodes, as well as from the lung and large intestine lamina
propria (LILP), produced amphiregulin upon stimulation with
phorbol-12-myristate-13-acetate (PMA) and ionomycin, albeit
to different extents (Figure 1A). Further analysis of the cell-sur-
face phenotype of amphiregulin-producing Foxp3– cells (Fig-
ure S1) showed that the majority of amphiregulin+ cells exhibited
very low expression of the homing receptor L-selectin (CD62L)
and high expression of CD44, whereas naive T cells failed to
produce amphiregulin (data not shown). Similarly, amphiregu-
lin-producing Treg cells were also mostly CD44hiCD62Llo and
exhibited elevated expression of CD103, PD-1, GITR, CTLA-4,
and KLRG1 in comparison to their amphiregulin-negative coun-
terparts, in agreement with two recent studies (Burzyn et al.,
2013b; Qi et al., 2012) (Figure 1B). Considering that a large num-
ber of Treg cells expressing amphiregulin also exhibit higher
levels of effector molecules that are important for their suppres-
sor function, we sought to unequivocally define the role and
function of amphiregulin expression by Treg cells using condi-
tional genetic deletion.
Mice expressing an amphiregulin (Areg) conditional allele on a
B6 genetic background (AregFl/Fl) were crossed to Foxp3YFP-cre
or CD4-cre mice to ablate amphiregulin in Foxp3+ Treg or all
T cells, respectively. Intracellular staining for amphiregulin
following stimulation with PMA and ionomycin confirmed its
Treg or pan-T-cell-specific loss in spleen, pLN, MLN, lung, andCell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc. 1079
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Figure 2. Treg- and T-Cell-Specific Ablation of Amphiregulin Does
Not Result in Immune Activation
(A–C) Flow cytometric analysis of cells isolated from spleens, axillary and
inguinal (pLN), and mesenteric (MLN) lymph nodes, lungs, and LILP of 3-
month-old AregFl/Fl (black), AregFl/FlFoxp3YFP-cre (blue), and AregFl/FlCD4-cre
(red) mice (see Experimental Procedures).
(A) Intracellular staining for amphiregulin (Areg) and Foxp3 within CD4+ T cells
following in vitro stimulation performed as described in Figure 1A. Specific loss
of amphiregulin expression in Foxp3+ Treg cells in AregFl/FlFoxp3YFP-cre mice
(middle) or all CD4+TCRb+ T cells in AregFl/FlCD4-cre mice (bottom) as
compared to AregFl/Fl control animals (top). The frequencies of cells within
each quadrant are shown.
(B) Ex vivo surface staining of CD4+Foxp3– (top) and CD8+ (bottom) conven-
tional T cells isolated from the indicated organs. Overlaid shaded histograms
depict expression of CD44 on T cells isolated from AregFl/Fl (black), AregFl/Fl
Foxp3YFP-cre (blue), and AregFl/FlCD4-cre (red) mice.
(C) Cytokine production by CD4+Foxp3– T cells stimulated in vitro as described
in Figure 1 legend. The data are shown as the frequency of CD4+Foxp3– T cells
producing each cytokine indicated in the top left corner of the plot. Shown as
mean ± SEM; comparisons to AregFl/Fl not statistically significant. Lng, lung;
LP, large intestine lamina propria (LILP). Data shown are representative of
more than 3 independent experiments (nR 3 mice per each group).
See also Figure S2.
1080 Cell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc.LILP (Figure 2A; data not shown). Animals were born in normal
Mendelian ratios with no gender bias, suggesting that T-cell-
restricted amphiregulin deficiency—contrary to its germline defi-
ciency—did not impair normal reproductive organ development
(data not shown) (Berasain and Avila, 2014). Furthermore, ani-
mals with amphiregulin deficiency in either Treg (Foxp3YFP-cre)
or all T cells (CD4-cre) showed similar frequencies and numbers
of B or T cells and activated T cells, assessed by CD44 expres-
sion, to those found in littermate controls up to4months of age
(Figures 2B and S2; data not shown). Germline Areg deficiency
had previously been shown to result in skin and intestinal abnor-
malities exacerbated upon exposure to ionizing irradiation (Shao
and Sheng, 2010; Zaiss et al., 2013). In contrast, in unchallenged
mice, pan-T or Treg-cell-specific Areg deletion resulted in no
gross phenotypic or histological abnormalities (data not shown).
Further assessment of CD4+ T helper (Th) cell subsets following
in vitro stimulation of lymphocytes isolated from various second-
ary and non-lymphoid tissues indicated that amphiregulin defi-
ciency did not influence the frequency or total number of Th1,
Th2, and Th17 cells (Figure 2C). Taken together, these data sug-
gest that, in a physiologic setting, amphiregulin expression by
T cells is dispensable for either organ development or the differ-
entiation of lymphocyte populations or their effector Th cell
polarization.
Amphiregulin Deficiency Does Not Affect Treg Cell
Suppressor Function
Recently, it was proposed that amphiregulin produced by Treg
cells may act in an auto- or paracrine manner to activate
EGF-R expressed on Treg cells and enhance their suppressive
capacity (Zaiss et al., 2013, 2015). However, we failed to iden-
tify heightened inflammatory responses in unchallenged mice
harboring amphiregulin-deficient Treg cells (or all T cells) as
would be expected if Treg cell immunosuppressive function
were noticeably impaired (Figures 2B and 2C). To directly test
whether amphiregulin production by Treg or effector T cells
can affect Treg-cell-mediated suppression in vitro, we assessed
the ability of amphiregulin-sufficient or -deficient CD4+CD25hi
Treg cells to suppress CD3-antibody-induced proliferation of
naive CD44loCD62LhiCD25–CD4+ T cells (Figure 3A). Irrespective
of whether responder or Treg cells were proficient or deficient
for amphiregulin, a similar degree of suppression was observed
(Figure 3B). Furthermore, antigen-presenting cell (APC)-
stimulated amphiregulin-deficient effector (‘‘effector only’’) or
suppressor (‘‘Treg only’’) cells responded identically to their
amphiregulin-sufficient counterparts (Figures 3A and 3B). Thus,
amphiregulin production by T cells is dispensable for suppress-
ing immune activation in vitro.
Nevertheless, it was possible that we may have missed a po-
tential modulatory role of amphiregulin in T cell responses. In this
regard, amphiregulin elaborated by bone marrow-derived cells
was suggested to promote Th2 responses during worm infection
(Zaiss et al., 2006). However, addition of increasing concentra-
tions of recombinant mouse amphiregulin (rmAREG) to fluores-
cence activated cell sorter (FACS)-purified naive CD4+CD44lo
CD62LhiCD25– Foxp3– T cells from Foxp3GFP mice stimulated
with plate-bound CD3 and soluble CD28 antibodies under Th0,








Figure 3. Amphiregulin Does Not Influence Effector Differentiation
or Mediate Suppression
(A and B) In vitro suppressor capacity of Treg cells is independent of am-
phiregulin expression. FACS-sorted naive CD4+CD44loCD62Lhi amphiregulin-
sufficient or -deficient T cells from (A) AregFl/Fl (solid lines/symbols) or (B)
AregFl/FlCD4-Cre (dashed lines/open symbols) mice, respectively, were
cultured with graded numbers of CD4+CD25hi Treg cells FACS sorted from
AregFl/Fl (black) or AregFl/FlCD4-Cre (red) animals in the presence of irradiated
T-cell-depleted splenocytes and 1 mg/ml CD3 antibody for 80 hr. T cell pro-effector T cell activation or cytokine production. In the presence
of amphiregulin, we observed comparable frequencies of cells
producing IFNg, IL-5, IL-13, and TNF-a within each set of polar-
ization conditions when compared to controls (Figure 3C). Since
conventional Foxp3–CD4+ T cells were also proficient for amphir-
egulin production, it was possible that amphiregulin produced by
these cells could increase the immunosuppressive capacity of
nearby Treg cells. However, consistent with some previous re-
ports, we failed to observe EGF-R expression or signaling in
Treg cells or an effect of endogenous amphiregulin expressed
in T cells or rmAREG in enhancing the induction or proliferation
of Treg cells in vitro (Figure 3B; J.A.G. and A.Y.R., unpublished
data) (Burzyn et al., 2013b).
To assess a role of amphiregulin production by Treg cells for
suppression in vivo, we adoptively transferred CD45.2+ amphir-
egulin-sufficient or -deficient YFP+ Treg cells FACS purified from
Aregwt/wtFoxp3YFP-cre and AregFl/FlFoxp3YFP-cre mice, respec-
tively, together with Foxp3-deficient effector CD45.1+CD4+
T cells isolated from Foxp3– mice into T-cell-deficient recipients
and monitored for signs of immune activation. Whereas animals
that received effector CD4+ T cells alone succumbed to autoim-
mune disease 5 weeks after transfer, those that received am-
phiregulin-sufficient and -deficient Treg cells were equally pro-
tected, showed no histopathological sequelae, and exhibited
comparable numbers, activation status, and pro-inflammatory
cytokine production by effector T cells (Figures 3D–3F; data
not shown). Furthermore, transferred Foxp3+ Treg cells wereliferation was assessed by incorporation of [3H]-thymidine added during the
final 8 hr of culture. Controls show proliferation under the same conditions for
naive CD4+ T cells in the absence of Treg cells (‘‘Effector Only’’) and Treg cells
incubated without effector cells (‘‘Treg only’’). Data are shown as mean ± SEM
and represent one of two independent experiments.
(C) Amphiregulin does not influence T helper cell polarization in vitro.
Flow cytometric analysis of cytokine production by FACS-sorted naive
CD4+CD44loCD62LhiCD25–Foxp3– T cells from Foxp3GFP reporter mice
cultured for 5 days with plate-bound CD3 and soluble CD28 antibodies in the
presence of IL-2 alone (Th0; left); in combination with IL-12, IFNg, and anti-
mouse IL-4 antibody (Th1; middle); or IL-4 in combination with IFNg and IL-12
neutralizing antibodies (Th2; right) with or without increasing amounts of
recombinant amphiregulin (as indicated by symbol size). Intracellular staining
for each indicated cytokine was performed following restimulation with PMA
and ionomycin in the presence of brefeldin A. Data are representative of three
independent experiments.
(D–G) Equivalent in vivo suppressor capacity of amphiregulin-deficient
and -sufficient Treg cells. Magnetic-bead-purified CD4+ T cells from Foxp3–
(CD45.1+) mice were transferred into Tcrb/Tcrd/ recipients alone (white
symbols; ‘‘Foxp3– effector only’’) or in combinationwith CD4+YFP+CD25hi Treg
cells from Aregwt/wtFoxp3YFP-cre (black) or AregFl/FlFoxp3YFP-cre (blue) mice. (D)
Changes in body weight were monitored and plotted as percent fromweight at
the date of transfer. Mice receiving only effector cells (‘‘Foxp3– effector only’’)
succumbed to autoimmunity and were euthanized (dashed line). The data
are shown as mean ± SEM; n = 5 (Aregwt/wtFoxp3YFP-cre), n = 5 (AregFl/FlFox-
p3
YFP-cre
), and n = 2 (Foxp3– Effector only). (E and F) Flow cytometric analysis of
(E) the frequency of proliferating (Ki67+; left) and IFNg-producing (right)
transferred CD45.1+CD4+ and (F) CD45.1+CD8+ Foxp3– effector cells and (G)
the frequency and expression levels of (H) Foxp3 (left) and CD25 (right)
of transferred CD45.2+ Treg cells from each indicated group, as labeled in (D).
The data are shown as mean ± SEM (n = 5 per group). No significant
differences were observed in recipients receiving Aregwt/wtFoxp3YFP-cre and
AregFl/FlFoxp3YFP-cre.







Figure 4. Production of Amphiregulin by Treg Cells Does Not Affect
Anti-Viral Immune Responses
(A and B) Flow cytometric analyses for amphiregulin (Areg) expression by cells
isolated from lungs of C57BL/6 mice that were intranasally instilled with PBS
(dpi 0) or infected with 0.5 LD50 PR8-OTI influenza (flu) virus at the indicated
time points (dpi: days post-infection).
(A) Representative flow cytometry plots of amphiregulin and Foxp3 expression
by CD4+ T cells directly following ex vivo isolation.
(B) Numbers of amphiregulin-expressing CD4+Foxp3– conventional T cells
(squares; ‘‘AREG+ Th’’), CD4+Foxp3+ Treg cells (circles; ‘‘AREG+ Treg’’), and
Lin–CD90+CD127+KLRG1+ST2+ ILC2 (triangles; ‘‘AREG+ILC2’’). Mean ± SEM.
Data are representative of 2 independent experiments (n R 3 mice per time
point in each group, except nR 2 per group in dpi 10 group in one of the two
experiments).
(C) AregFl/Fl (black), AregFl/FlFoxp3YFP-cre (blue), and AregFl/FlCD4-cre (red)
mice were intranasally instilled with PBS (solid symbols; ‘‘mock’’) or infected
with 0.5 median lethal dose (LD50) PR8-OTI (open symbols; ‘‘PR8-OTI’’).
Changes in body weight were monitored daily in infected and control
groups (dpi). The data are shown as mean percent weight ± SEM of
weight at dpi 0. No significant differences were found between infected
AregFl/FlFoxp3YFP-cre or AregFl/FlCD4-cre groups as compared to infected
AregFl/Fl group (n = 4 per group except for n = 3 per group for mock-treated
1082 Cell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc.present in similar numbers and expressed comparable amounts
of Foxp3 and CD25 on a per-cell basis (Figures 3G and 3H).
Thus, Treg-cell-derived amphiregulin was dispensable for elab-
oration or potentiation of suppressor function or maintenance.
Amphiregulin Production by Lung Treg Cells Prevents
Tissue Damage but Is Dispensable for Regulation of
Virus-Specific Immune Responses
Next, we asked whether Treg-cell-derived amphiregulin has a
non-redundant role in tissue repair. It remained possible that,
in settings of tissue injury, amphiregulin produced by Treg cells
could suppress immune responses. To address this question,
we used an intranasal influenza virus infection model, where
a general role for amphiregulin in repairing lung injury and
Treg-cell-mediated suppression of pathogen-specific immune
responses has been well documented (Brincks et al., 2013;
Jamieson et al., 2013; Monticelli et al., 2011). In addition, flu
infection enables tracking of virus-specific immune responses,
as well as pathogen and antigen load in the affected tissue (Bed-
oya et al., 2013; Brincks et al., 2013; Moser et al., 2014). Intra-
nasal infection of mice with influenza A virus strain A/Puerto
Rico/8/34 (PR8) encoding H-2Kb ovalbumin peptide epitope,
OVA257-264 (PR8-OTI), induces robust alveolar epithelial damage
early after infection, and the virus-specific T cell response is
required for viral clearance (Epstein et al., 1998).
Since multiple cell types are capable of amphiregulin produc-
tion, we first sought to assess dynamics of amphiregulin expres-
sion during the course of infection. We observed a rapid increase
in both transcript and protein levels of amphiregulin in whole-
lung tissue homogenate beginning at day 3 post-infection,
followed by a decrease after day 5 (Figure S3A). The observed
changes in total amphiregulin amounts in the infected lungs
tightly corresponded with an increase in amphiregulin produc-
tion by lung Treg cells assessed by flow cytometry, with amphir-
egulin staining performed directly following ex vivo isolation of
cells (Figure 4A). The observed high level of amphiregulin expres-
sion by lung Treg cells was not a result of its buildup due to an
impaired proteolytic cleavage of cell-surface-bound amphiregu-
lin, as evidenced by a marked increase in amphiregulin staining
following in vitro incubation of lung lymphocytes with the matrix
metalloproteinase (MMP) inhibitor, marimastat, when compared
to control (Figure S3B). The marked early increase in amphiregu-
lin-expressing cells on days 3 and 5 post-infection was limited to
the lung Treg cell population. In contrast, an increase in theAregFl/FlFoxp3YFP-cre mice). Data are representative of R3 independent
experiments.
(D–G) Flow cytometric analysis of the frequency of virus-specific (D)
CD8+CD44hi and (E) CD4+Foxp3–CD44hi, (F) IFNg (left), and IL-17-producing
(right) CD4+Foxp3–, and (G) IFNg-producing CD8+ T cells in spleen, lung, and
lung-draining lymph nodes (LDLN) of AregFl/Fl (black), AregFl/FlFoxp3YFP-cre
(blue), and AregFl/FlCD4-cre (red) mice infected with 0.5 LD50 PR8-OTI at dpi
10. Mean ± SEM. Data are representative of R3 independent experiments
(nR 3 mice per group).
(H) Influenza virus load on dpi 8 in lung tissue of AregFl/Fl (black), AregFl/Fl
Foxp3YFP-cre (blue), and AregFl/FlCD4-cre (red) mice infected as in (C), as
determined by TCID50. Data are shown as TCID50/mg of lung tissue analyzed.
Mean ± SEM. Data are representative of three independent experiments.







Figure 5. Lung Treg Cells Prevent Tissue
Damage through the Production of Am-
phiregulin
(A) Blood oxygen saturation (SpO2) in Areg
Fl/Fl (solid
black and dashed green) and AregFl/FlFoxp3YFP-cre
(blue) mice following control treatment with PBS
(solid symbols; ‘‘mock’’) or infection with 0.5 LD50
PR8-OTI flu virus (open symbols; ‘‘PR8-OTI’’)
measured at the indicated dpi. The data are shown
asmean ± SEM (n = 4 per group except for n = 3 per
group for mock-treated AregFl/FlFoxp3YFP-cre mice).
Depicted p value corresponds to comparison of in-
fected AregFl/Fl with infected AregFl/FlFoxp3YFP-cre;
the difference between control AregFl/Fl to control
AregFl/FlFoxp3YFP-crewas not statistically significant.
(B–F) Histopathological analysis of lungs from
AregFl/Fl and AregFl/FlFoxp3YFP-cre mice following
infection with 0.5 LD50 PR8-OTI virus as in (A), at
dpi 8.
(B) Representative H&E stained histologic sections
depicting prominent BEL in AregFl/FlFoxp3YFP-cre
lung (between filled arrowheads; right) in contrast
to hyperplastic bronchial epithelium in AregFl/Fl
(open arrowhead; left). Asterisk (*) marks bronchi-
olar lumen.
(C) Quantification of increased severity (left) and
extent (E1; right) of tissue damage, as measured by
BEL, LA, increasedcell debris, andAE.Mean±SEM.
(D) AE is marked in the subpleural region of histo-
logical sections from lungs of AregFl/FlFoxp3YFP-cre
(right); alveoli (‘‘a’’).
(E and F) Immunohistochemical staining for influenza virus protein antigens is (E) intensely positive in AregFl/FlFoxp3YFP-cre (right) bronchial epithelium, alveolar
macrophages (solid arrows), and sloughed cellular debris. Similar but less intense staining is noted in infected AregFl/Fl (left) lung. (F) Alveolar edema stains
intensely positive for influenza antigen by immunohistochemistry; in contrast, in AregFl/Fl lung sections (left), only cell-associated immunohistochemical signal
(open arrows) is noted. Insets are negative control of same section; alveoli (‘‘a’’), bronchiolar lumen (*).
(G) Quantification of interstitial and total signal intensity (see the Supplemental Experimental Procedures) and disease severity using image analysis software
(left) and histological scoring (right) of sections from all mice stained as in (F). Original magnification all panels is 203. Mean ± SEM. Data are representative of
one of 2 independent experiments (n R 3 mice per group).
See also Figure S4.number of other lung lymphocytes producing amphiregulin,
namely Foxp3–CD4+amphiregulin+ T cells and amphiregulin+
ILC2, was not observed until days 8 and 10 post-infection. This
exclusive increase in amphiregulin+ Treg cells did not seem to
be a result of preferential expansion of preexisting amphiregu-
lin-expressing lung Treg cells at early time points. In fact, overall
numbers of lung effector CD4+ and CD8+ T cells were already
increased at day 3, whereas lung ILC2 displayed a delayed in-
crease in numbers between days 5 and 8 post-infection when
compared to numbers of corresponding cell subsets in lungs
from control uninfected mice (Figures 4B, and S3C, and S3D).
Next, we tested whether the observed early amphiregulin pro-
duction by Treg cells has a role in promoting tissue repair during
infection or in controlling antiviral immune responses by infecting
AregFl/FlFoxp3YFP-cre and littermate control mice. To account for
the potential contribution of amphiregulin production by effector
T cells, we also examined flu-infected AregFl/FlCD4-Cre mice.
Following intranasal infection, all groups of mice displayed an
equivalent reduction in body weight (Figure 4C). Analysis of
lung T cells at day 8 or 10 post-infection revealed comparable
frequencies of CD44hiCD62Llo and Ki67+ cells, suggesting that
overall T cell activation is unaffected by Treg or T-cell-restricted
amphiregulin deficiency (Figure S3E). Furthermore, virus-spe-cific CD8+ and CD4+ T cell responses in the lung, lung-draining
lymph nodes, (LDLN) and spleen, assessed by H2-KbOVA257-264
and H2-I-Ab NP311-325 tetramer staining, respectively, were com-
parable in all groups of mice at the peak of the response on days
8–10 post-infection (Figures 4D and 4E). In addition, cytokine
production by lung T cells was comparable in all groups of
mice (Figures 4F and 4G). Importantly, similar antigen-specific
T cell expansion and activation was accompanied with a compa-
rable viral load in control mice and those harboring amphiregulin-
deficient Treg cells or all T cells (Figure 4H). Thus, amphiregulin
production by Treg cells was fully dispensable for Treg-cell-
mediated suppression of anti-viral immunity.
To account for a potential role of Treg-cell-derived amphiregu-
lin in tissue repair, we assessed physiological and histological
parameters of lung damage following infection. In the absence
of amphiregulin production by Treg cells, we observed a rapid
decline in lung function, as measured by pulse oximetry, with
average blood oxygen saturation levels falling below 80% as
early as day 4 and below 60% at later time points post-infec-
tion of AregFl/FlFoxp3YFP-cre mice (Figure 5A). In contrast, control
animals did not exhibit blood oxygen saturation levels measuring
less than 80% throughout the course of the infection. The
comparably severe impairment in lung function observed inCell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc. 1083
AregFl/FlCD4-Cre (Figure S4A) mice suggested that Treg cells—
not effector T cells—serve as a key source of amphiregulin and
was consistent with the dynamics of amphiregulin produced by
lung adaptive and innate lymphocyte subsets (Figures 4A, 4B,
and S3D). Furthermore, histopathological analysis revealed a
markedly increased severity and extent (E1) of overall tissue
damage, as quantified by bronchial epithelial loss (BEL),
lymphoid aggregation (LA), and increased accumulations of
cell debris and edema (AE) in the alveolar space of mice lacking
amphiregulin in Treg cells or in all T cells (Figures 5B–5D and
S4B). It must be noted that both AregFl/FlFoxp3YFP-cre and
AregFl/FlCD4-cre mice eventually clear the infection and repair
lung damage, whereas low-dose infection does not result in
substantial lung damage or impaired blood oxygenation due to
rapid viral clearance (data not shown).
Consistent with a role of Treg cells as an early source of
amphiregulin, both AregFl/FlFoxp3YFP-cre and AregFl/FlCD4-cre
mice exhibited decreased total amounts of amphiregulin in bron-
choalveolar lavage (BAL) fluid and lung tissue on day 5 of infec-
tion in comparison to control mice (Figure S4C). Immunohisto-
chemical staining for viral protein provided additional evidence
that barrier integrity and tissue architecture were compromised
(Figure 5E). Whereas control animals exhibited punctate staining
localized within alveolar and bronchiolar epithelial cells or
sloughed cells confined to the luminal space, lung tissue of in-
fected AregFl/FlFoxp3YFP-cre and AregFl/FlCD4-cre mice exhibited
increased staining throughout sections. Thus, despite compara-
ble control of viral replication, viral proteins were diffusing—most
likely with necrotic debris and edema fluid—into the paren-
chyma, potentially impeding the transfer of oxygen into circu-
lating blood (Figures 5F, 5G, and S4B). The observed decrease
in blood oxygenation was unlikely a result of increased microbial
translocation due to increased gut permeability because C-reac-
tive protein (CRP) and serum LPS levels were unaffected (Fig-
ure S4D; data not shown). Likewise, it was not a consequence
of anemia because AregFl/FlFoxp3YFP-cre and AregFl/FlCD4-cre
mice had unperturbed hematocrit, red blood cell counts, and
hemoglobin concentrations (Figure S4E). Consistent with the
decreased capillary oxygenation, we observed decreased sur-
face temperature in AregFl/FlFoxp3YFP-cre and AregFl/FlCD4-cre
mice, whereas core body temperature was comparable to that
in respective control groups (Figure S4F). These results demon-
strate a key role for Treg-cell-derived amphiregulin in mediating
tissue protection and maintaining barrier integrity in response to
infectious stimuli-induced tissue damage.
IL-18 and IL-33 but Not TCR Signaling Elicit
Amphiregulin Production in Treg Cells
We next questioned whether amphiregulin production by Treg
cells—a distinct functional modality for promoting tissue pro-
tection—is mobilized in response to the same or separable
cues from those eliciting their suppressor function, the latter
being elicited by, and dependent upon, TCR signaling (Levine
et al., 2014; Wu et al., 2006). Thus, it was possible that amphir-
egulin production is also induced in response to TCR signaling
to simultaneously invoke Treg cell suppressor and tissue repair
function. Alternatively, inflammatory mediators or alarmins
released upon tissue damage might serve as distinct and bio-1084 Cell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc.logically relevant cues for amphiregulin production in Treg
cells. Indeed, previous studies showed that the alarmin IL-33
induces amphiregulin production in lung ILC2 in vitro, and
high levels of amphiregulin expression were reported in ST2-
expressing Treg cells in the gut and VAT (Burzyn et al.,
2013b; Cipolletta et al., 2012; Feuerer et al., 2009; Monticelli
et al., 2011; Schiering et al., 2014). Thus, alarmins IL-33 and
IL-1a and inflammatory cytokines IL-18 and IL-1b, prominently
expressed at mucosal epithelial surfaces, were likely candi-
dates to mobilize an amphiregulin-dependent tissue repair
functionality of Treg cells.
To test this hypothesis, FACS-purified GFP+ Treg cells from
Foxp3GFP mice were incubated in vitro with IL-33, IL-18, IL-1a,
IL-1b, or related cytokines IL-36a, b, or g in the presence of
IL-2 and IL-7, with or without stimulation with CD3 and CD28
antibody-coated beads. Quantification of cell-associated and
secreted amphiregulin by flow cytometry and ELISA, respec-
tively, showed that both IL-18 or IL-33 stimulation led to a
marked increase in the level of secreted amphiregulin and was
independent of TCR engagement, whereas IL-1a, IL-1b, and
IL-36 family members failed to increase amphiregulin over
4 days in culture (Figures 6A and S5A). Amphiregulin production
was limited to Treg cells expressing receptors for IL-18 (IL18R1;
CD218a) and IL-33 (ST2), and amphiregulin secretion was
dependent on receptor expression (Figures S5B and S5C; data
not shown). Although IL-18 and IL-33 aided Treg cell expansion,
amphiregulin protein levels produced on a per cell basis were still
markedly increased (Figure 6B). In contrast, TCR stimulation in
the presence of IL-2 induced proliferation and production of IL-
10, whose non-redundant role in Treg cell suppressor function
has been well documented (Figure 6C) (Asseman et al., 1999;
Rubtsov et al., 2008). Notably, TCR stimulation not only failed
to potentiate amphiregulin production on a per cell basis but
also led to a reduction in cell-associated amphiregulin levels,
likely due to expansion of amphiregulin-negative cells (Figures
6B and 6D). These results support the idea that amphiregulin
is produced in response to signals distinct from those eliciting
suppressor function.
Next, we assessed lung tissue levels of IL-18 and IL-33 and
expression of their receptors, IL-18R and ST2, respectively,
and amphiregulin production by lung Treg cells after influenza
infection. Throughout the course of the infection, ST2 was
present on no greater than 50% of cells staining positively for
amphiregulin, and at day 3 post-infection, when Treg cells
first began expressing detectable levels of amphiregulin, only
30% of cells were positive for both amphiregulin and ST2
(Figure 6E). We observed, however, significant expansion of
IL-18R+ Treg cells. This subset of Treg cells exhibited the highest
proliferative activity very early following infection (Figures S5D
and S5E). Furthermore, whereas few amphiregulin+ Treg cells
were ST2+, 80% of amphiregulin-producing Treg cells were
IL-18R+ (amphiregulin+IL-18R+) and expressed the highest
amount of amphiregulin on a per-cell basis (Figures 6F and
S5F). Accordingly, the majority of amphiregulin+ST2+ Treg cells
co-expressed IL-18R (amphiregulin+IL-18R+ST2+; Figure 6G).
Consistent with these observations, IL-18 was present at
approximately two log higher concentration than IL-33 in BAL





Figure 6. IL-18 and IL-33 Signaling in Treg Cells Induces Production of Amphiregulin
(A–D) FACS-sorted CD4+Foxp3+ Treg cells from Foxp3GFP reporter mice were cultured in vitro with each of the indicated alarmins, IL-18, or IL-1b, in the presence of
IL-2 and IL-7, with (‘‘TCRstim’’; red) or without (‘‘Unstim’’; black) stimulation with CD3 and CD28 antibody-coated beads for 4 days followed by quantification of (A)
total and normalized per cell (B) amphiregulin amounts and (C) IL-10 protein levels by ELISA of cell-free culture supernatants and flow cytometric analysis of cell
pellets for determining total viable cell numbers (used for normalization in B andC) and (D) remaining protein levels of cell-associated amphiregulin. In the absence of
TCR stimulation, IL-10 levels are below the limit of detection. The data are shown as mean ± SEM. Data are representative ofR3 independent experiments.
(E and F) The (E) frequency of amphiregulin+ST2+ cells, (F) representative flow cytometry plots depicting amphiregulin and ST2 (top) or IL-18R (bottom)
expression, and the (G) frequency of amphiregulin expressing IL-18R+ST2–, IL-18R–ST2+, and IL-18R+ST2+ cells determined by flow cytometric analysis of
CD4+Foxp3+ Treg cells isolated from lungs of C57BL/6 mice following intranasal instillation with (F) PBS (dpi 0) or (E–G) infection with 0.5 LD50 PR8-OTI virus on
the indicated dpi. Data are representative of 2 independent experiments (nR 3mice per group except nR 2 in dpi 10 group in one of the two experiments). Data in
(E) and (G) are presented as mean ± SEM.
(H) Treg cell production of amphiregulin in response to influenza infection-induced tissuedamageoccurs in a TCR-independentmanner.Tcrawt/FlFoxp3eGFP-Cre-ERT2
micewere gavaged twice with tamoxifen to induce deletion of a conditionalTcra allele and TCRablation. Twoweeks later, treatedmicewere infectedwith 0.5 LD50
PR8-OTI, and lung leukocytes were analyzed directly ex vivo by flow cytometry for amphiregulin production on dpi 5 using intracellular staining. Representative
histograms (left) and MFI plots (right) depict the level of amphiregulin expression in TCR+ and TCR– CD4+Foxp3+ Treg cells. TCR expression was detected using
TCRb-specific monoclonal antibody staining. MFI data are presented as mean ± SEM. Data are representative of nR 10 mice.
See also Figure S5.To investigate whether Treg cells are capable of producing
amphiregulin in a TCR-independent manner in vivo, previously
characterized Tcrawt/FlFoxp3eGFP-Cre-ERT2 mice were treated
with tamoxifen 14 days prior to infection with PR8 influenza virus
to ablate TCR in a portion of Treg cells due to Tcra allelic exclu-
sion. Efficient production of amphiregulin by ex-vivo-isolated
TCR-deficient Treg cells on day 5 post-infection was indicative
of independence from TCR signaling (Figure 6H). Thus, thesestudies suggested that the amphiregulin-mediated tissue pro-
tective function of Treg cells is induced in response to distinct
cues, namely, inflammatory mediator IL-18 and alarmin IL-33,
but not TCR signaling, which promotes suppressor function.
Our finding that the majority of amphiregulin-producing Treg
cells expressed IL-18R presented an opportunity to explore
the transcriptional features associated with amphiregulin
expression in Treg cells and their tissue repair function. ForCell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc. 1085
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Figure 7. TregCells Poised for Amphiregulin
Production Display a Distinct Gene Expres-
sion Profile
(A–C) RNA-seq analysis of Treg cell subsets
isolated from lungs of Il10GFPFoxp3Thy1$1 mice.
Thy1.1+ Treg cells were FACS sorted into IL-10–IL-
18R–, IL-10+IL-18R–, and IL-10–IL-18R+ pop-
ulations on day 5 following intranasal infection with
0.5 LD50 PR8-OTI. Differential gene expression
between IL-10+IL-18R– and IL-10–IL-18R+ pop-
ulations is shown as (A) fold-change-fold-change
plot of IL-10+IL-18R– versus IL-10–IL-18R– and IL-
10–IL-18R+ versus IL-10–IL-18R– highlighting
genes exhibiting >2-fold (p < 0.01) increase in IL-
10+IL-18R– versus IL-10–IL-18R+ (green dots) and
IL-10–IL-18R+ versus IL-10+IL-18R– (blue dots) or
(B) >2-fold increase (p < 0.01; shown in [A] as IL-
10+IL-18R– versus IL-10–IL-18R–, green dashed
line and IL-10–IL-18R+ versus IL-10–IL-18R–, blue
dashed line) in IL-10+IL-18R– versus IL-10–IL-18R–
and IL-10–IL-18R+ versus IL-10–IL-18R– (beige),
IL-10+IL-18R– versus IL-10–IL-18R– relative to IL-
10–IL-18R+ versus IL-10–IL-18R– (green), or
IL-10–IL-18R+ versus IL-10–IL-18R– relative to IL-
10+IL-18R– versus IL-10–IL-18R– (blue), as de-
picted by Venn diagram and (C) heatmap of genes
with significant gene expression (n = 5 mice per
population sequenced).
See also Figure S6.comparison, we sought to examine RNA expression in IL-10-ex-
pressing cells as representatives of ‘‘effector’’ Treg cells with a
TCR signaling-dependent immunosuppressive function. To
assess the transcriptional profiles of cells receiving these
different contextual inputs, the following activated Thy1.1+
Treg cell populations were FACS-purified from infected Il10GFP
Foxp3Thy1.1 mice based on the expression of either IL-10
(GFP+) or IL-18R (CD218a+): (1) IL-10–IL-18R–, (2) IL-10+IL-
18R–, and (3) IL-10–IL-18R+. We isolated cells on day 5 post-
infection, when significant numbers of Treg cells produce am-
phiregulin and when amphiregulin-producing conventional
T cells have yet to undergo marked expansion (Figure 4A).
Genome-wide transcriptional analysis by RNA sequencing
(RNA-seq) confirmed that lung IL-10+IL-18R– and IL-10–IL-
18R+ Treg cells exhibited a similar activation phenotype relative
to double-negative IL-10–IL-18R– cells, with > 90% of shared
differentially expressed genes (p < 0.01; > 2-fold change) (Fig-
ures 7A, 7B, and S6A). Lung IL-10+IL-18R– Treg cells exhibited
a heightened, previously defined TCR-dependent activation
signature of CD44hiCD62Llo Treg cells (Figure S6B) (Arvey
et al., 2014; Levine et al., 2014). Enrichment for a Treg cell
activation signature specific to IL-10+IL-18R– cells suggested1086 Cell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc.that these cells experienced potent
TCR-dependent stimulation unlike IL-
10–IL-18R+ cells. Despite being markedly
different in amphiregulin protein expres-
sion, both populations of cells featured
increased amounts amphiregulin tran-
script in comparison to IL-10–IL-18R–
Treg cells. This was likely because expo-sure of some of these cells to IL-33, or a yet-to-be-identified
factor, induced amphiregulin mRNA in IL-10+IL-18R– Treg cells.
In addition, the IL-10+IL-18R– Treg cell subset showed a statisti-
cally significant increase in amounts of IL-18R (Il18r1) mRNA in
comparison to the IL-10–IL-18R– Treg cell subset, suggesting
that some of the former may have been stimulated by IL-18,
but downregulated IL-18R on the cell surface. Finally, it must
be noted that the increased amphiregulin mRNA amounts does
not necessarily mean that membrane-bound or secreted am-
phiregulin protein is also expressed.
A number of genes unique to IL-10+IL-18R– Treg cells have
previously been shown to correlate with high immunosuppres-
sive potential (Figure 7C). Interestingly, this gene set was highly
reminiscent of those previously reported in Treg cells isolated
from VAT during high-fat-diet-induced obesity and from injured
skeletal muscle (Burzyn et al., 2013b; Cipolletta et al., 2012; Feu-
erer et al., 2009). Of these genes, the most pronounced overlap
was observed for genes related to Treg cell suppressor function,
e.g., Lag3, Gzmb, Tnfrsf8 (CD30), and Entpd1 (CD39) (Josefo-
wicz et al., 2012). This pattern highlighted the notion that lung
IL-10-producing Treg cells from infected mice exhibited high
immunosuppressive potential. Analysis of transcripts selectively
upregulated in IL-10–IL-18R+ versus IL-10+IL-18R– Treg cells
(Figure 7C) suggested that the former population is proficient
in extracellularmatrix (ECM) remodeling and tissue repair. Genes
expressed by this population encompass core matrisome and
matrisome-associated components (http://matrisomeproject.
mit.edu). These results suggest that Treg cells capable of tissue
repair exhibit a discrete gene expression pattern consistent with
the idea that distinct contextual inputs facilitate Treg cell tissue
repair and immunosuppressive effector modalities.
DISCUSSION
It has been proposed that Treg cells serve multiple functions
beyond their initially characterized role in suppressing autoim-
munity (Burzyn et al., 2013a; Josefowicz et al., 2012). Depend-
ing on tissue localization, transcription factor expression, and
activation status, Treg cells may adopt specialized capabilities
for affecting function of hematopoietic and non-hematopoietic
cells. Here, using influenza lung infection as a model of path-
ogen-induced immunity, inflammation, and tissue damage, we
demonstrate an essential role for Treg cells in tissue protec-
tion—separable from their well-established function in suppres-
sion of the immune response. The ability of Treg cells to pre-
serve lung structural and functional integrity early during
influenza infection was conditional upon their production of
amphiregulin.
Recently, Treg cells have been implicated in response to tis-
sue damage based on an impairment in muscle regeneration
observed upon systemic Treg cell ablation following muscle
injury, with systemic administration of recombinant amphiregulin
capable of rescuing the defect (Burzyn et al., 2013b). However,
acute Treg cell deficiency results in autoimmunity, with massive
expansion and recruitment of pro-inflammatory monocytes and
activation of myeloid cells, which fuel severe inflammation and
tissue damage (Kim et al., 2007). Furthermore, generalized deliv-
ery of amphiregulin is capable of rescuing tissue function in a va-
riety of settings, including lung failure during bacterial and viral
co-infection, and many cell types are capable of producing am-
phiregulin, including basophils, ILC2, mast cells, Treg, effector
CD4 and CD8 T cells, and smooth-muscle cells (Deacon and
Knox, 2015; Jamieson et al., 2013; Zaiss et al., 2015). Treg cells
muffle pro-inflammatory gene activation; the blunted recruitment
and responses of inflammatory cells curtail positive-feedback
loops mediated by activated T cells and promote a switch from
an inflammatory to a tissue repair program. Thus, it is possible
that the impairment in tissue repair observed in the absence of
Treg cells was an indirect consequence of increased systemic
immune activation and inflammation.
Our study suggests that Treg cells have the capacity to directly
exert tissue repair function, at least in part, through production of
amphiregulin. Although seemingly unexpected in light of the
aforementioned multiple cellular sources, the non-redundant
role for amphiregulin produced by Treg cells was consistent
with our finding that they represented themost numerous cellular
source of amphiregulin mobilized early in the response to tissue
damage. It must be noted thatAregFl/FlFoxp3YFP-cremice cleared
the infection, and lungs were eventually repaired likely due to
contribution of amphireglin, produced by other cell types, andof epiregulin and EGF, which, together with amphiregulin, act
upon an overlapping set of receptors. The importance of amphir-
egulin production by T cells was dependent on the extent of
infection-induced damage because we observed comparable
lung function in mutant and wild-type mice upon low-dose flu
infection (data not shown). It is also likely that the outcome of
Treg-cell-restricted amphiregulin deficiency could be much
more dramatic upon bacterial co-infection.
Recently, ILC2-derived amphiregulin was shown to be simi-
larly required for limiting lung tissue damage in influenza-virus-
infected Rag1/ mice lacking T and B cells (Monticelli et al.,
2011). Although we cannot formally demonstrate or dismiss a
role for amphiregulin+ ILC2 in response to influenza infection in
lymphoreplete animals, we find that amphiregulin+ Treg cells
far outnumber amphiregulin+ ILC2 as early as 3 days post-infec-
tion, when differences in lung function begin to be observed. It is
also important to consider that ILC2 are present in higher
numbers in RAG-deficient mice than in wild-type mice and
that, upon challenge, ILC2 may expand more significantly in
the former animals.
Treg cells are capable of suppressing immune responses
against influenza virus and assisting in animal recovery after viral
infection is cleared (Bedoya et al., 2013; Brincks et al., 2013;
Moser et al., 2014). In light of these results, it is important to
emphasize that no detectable impairment in Treg cell suppressor
capacity or their numbers or activation status was observed in
unchallenged animals, in settings of T cell-mediated systemic
autoimmunity, or during infection. These findings were contrary
to previous conjecture of an autocrine role for amphiregulin in
immunosuppression (Meulenbroeks et al., 2015; Zaiss et al.,
2013, 2015).
In contrast to TCR and IL-2 signaling-induced suppressor
function, Treg cell tissue repair capacity manifested by produc-
tion of amphiregulin was not facilitated in an ‘‘adaptive manner’’
by TCR engagement in vitro or in vivo. In contrast, it can be
induced in an ‘‘innate’’ manner by IL-18 and IL-33, whose release
is associated with inflammation and tissue injury. Although the
extent of their relative contribution to the induction of a Treg
cell tissue repair modality in vivo remains to be experimentally
tested, the majority of IL-18R-expressing Treg cells produced
amphiregulin in the lungs of infected animals. Particular tran-
scriptional features of these cells suggested that they were pro-
ficient in tissue protection or repair. It is noteworthy that Treg
cells isolated from other tissues, including injured skeletal mus-
cle, inflamed colon, and adipose tissue, express ST2 and IL-18R
(Burzyn et al., 2013b; Harrison et al., 2015; Schiering et al., 2014;
Vasanthakumar et al., 2015). Our analysis of influenza infection in
mixed bone marrow chimeras generated upon transfer of IL-
18R-deficient and Foxp3-deficient bone marrow cells into irradi-
ated lymphopenic recipients also supported a prominent role for
IL-18R signaling in Treg cells for their tissue protective function
in vivo (S.H., N.A., and A.Y.R., unpublished data). Our studies
suggest that IL-18 likely has a dual role in promoting inflamma-
tory responses when acting upon immune effector cells and alle-
viating or preventing tissue damage and loss of tissue function
when acting upon Treg cells. Such a dual role for IL-18 is reminis-
cent of IL-2, which promotes both effector T cell responses and
Treg cell suppressor function (Liao et al., 2013).Cell 162, 1078–1089, August 27, 2015 ª2015 Elsevier Inc. 1087
In conclusion, our study provides evidence that Treg cells
have a distinct function in protective responses to tissue injury,
repair, and maintenance and that this function of Treg cells is
invoked in response to cues that are separable from those
invoking their suppressor capacity.
EXPERIMENTAL PROCEDURES
Mice
AregFl/Fl mice were generated using mouse B6 ES cells obtained through the
EUCOMM (European Conditional Mouse Mutagenesis Program) consortium.
AregFl/Fl allele was bred to Foxp3YFP-cre and CD4-cre mice, and mice were
screened for maintenance of the C57BL/6N Nnt allele. C57BL/6NCr mice
were purchased from Charles River. For details of AregFl/Fl and other mice
used in this study, see the Supplemental Experimental Procedures. Genera-
tion and treatments of mice were performed under protocol 08-10-023
approved by the Sloan Kettering Institute (SKI) Institutional Animal Care and
Use Committee. All mouse strains were maintained in the SKI animal facility
in accordance with institutional guidelines.
Cell Isolation
Spleens and lymph node cell suspensions were prepared and red blood cell
(RBC) were lysed using ammonium chloride (ACK; Sigma) buffer followed by
repeated washing in RPMI1640 medium, 5% fetal bovine serum (FBS; Corn-
ing). For isolation of lymphocytes from lung and LILP, tissues were digested
with collagenase A (1 mg/ml, Roche) and DNase I (0.5 mg/ml, Roche) in
RPMI1640 for 30 min at 37C. For some experiments, CD4+ T cells were en-
riched using the Dynabeads FlowComp mouse CD4 kit (Life Technologies)
and sorted using an Aria II cell sorter (BD Biosciences).
In Vitro Assays
For the analysis of amphiregulin production, ex vivo isolated cells were stimu-
lated, where noted, with PMA (50 ng/ml, Sigma) and ionomycin (1 nM, Calbio-
chem) for 3 hr in the presence of marimastat (10 mM, Sigma) and GolgiPlug
(brefeldin A) and GolgiStop (monensin; BD Biosciences) or stained directly
ex vivo following isolation from infected lungs. Secreted amphiregulin and
IL-10 were quantified using mouse Amphiregulin DuoSet (R&D) and IL-10
Ready-SET-Go! (eBioscience) ELISA kits. In vitro suppression assays were
performed as previously described (Arpaia et al., 2013). For a complete list
of recombinant cytokine concentrations and in vitro polarization conditions,
see the Supplemental Experimental Procedures.
Influenza Virus Infection
Recombinant influenza A strain PR8-OTI (H1N1) was grown for 40 hr in the
allantoic cavity of 10-day-old embryonated chicken eggs (Charles River) and
titer was determined by plaque immunostaining. For details, see the Supple-
mental Experimental Procedures.
RNA Sequencing
Treg cells isolated from lungs of flu-infected Il10GFPFoxp3Thy1.1 mice were
FACS sorted directly into TRIzol LS reagent (Life Technologies) based on
expression of GFP and IL-18R (CD218a) staining at 5 days post-infection.
Extracted RNA was amplified by SMART amplification (Clontech) prior to gen-
eration of cDNA libraries (see the Supplemental Experimental Procedures).
Statistical Analyses
Unless otherwise noted, data are presented as mean ± SEM, with significance
calculations determined by Student’s t test or ANOVA using Prism software
(GraphPad). A value of p > 0.05 was deemed not statistically significant (ns);
*p% 0.05, **p% 0.01, ***p% 0.001, and ****p% 0.0001.
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